comparemela.com

Latest Breaking News On - Glaucoma therapeutics - Page 2 : comparemela.com

Worldwide Glaucoma Therapeutics Industry to 2026 - Featuring Novartis, Pfizer and SIFI Among Others

Outlook on the Glaucoma Therapeutics Global Market to 2025

Share this article Share this article ResearchAndMarkets.com s offering. The global glaucoma therapeutics market grew at a CAGR of around 4% during 2014-2019. Glaucoma therapeutics refers to various treatment alternatives for primary open-angle (POA) and primary angle-closure (PAC) glaucoma. The disease is characterized by structural changes in the optic nerves that usually lead to visual loss and blindness. The treatment for glaucoma can be initiated through topical eye drops, which majorly consist of beta-blockers, prostaglandin analogs, cholinergic, carbonic anhydrase inhibitors and alpha-adrenergic agonists. These eye drops minimize the production of fluid in the eyes, thereby reducing the intraocular pressure (IOP). This can be followed by traditional or laser surgical procedures or a combination of both, which use products such as implantable extended-release devices, polymer-based contact lenses, drug-eluting punctal plugs, microneedle-injection devices and micro-dosing tec

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.